Palisades Plant: A Delayed Dream with Big Risks

The Palisades nuclear plant, located near Lake Michigan, was shut down in 2022 and is now the focus of a controversial restart plan by Holtec International, a company with no prior operating experience. Holtec hopes to become the first firm to reopen a plant that has been closed for decommissioning, but the effort is fraught with safety questions and regulatory hurdles. The company has faced repeated setbacks, pushing the project back by months while still receiving significant public funds. In June 2024, Holtec applied to the Nuclear Regulatory Commission (NRC) for permission to correct welding work that was done without proper approval. This request follows a 2025 amendment to Palisades’ fire safety plan and an earlier NRC exemption that allowed the repair of cracked steam‑generator tubes. An incident in October 2025, when a worker fell into the reactor vessel, added another layer of scrutiny. After Governor Whitmer announced Michigan’s first nuclear restart, the NRC issued a letter on February 12 indicating that its review schedule had changed and would likely extend to April. The agency warned that additional information requests could further delay the process, a fact that surprised many investors and industry observers.Holtec’s appeal is unprecedented in the history of U. S. nuclear power, and it raises concerns about whether the plant can meet current safety standards. In a January filing, Holtec admitted that some welding did not comply with American Society of Mechanical Engineers (ASME) codes, a serious breach that could undermine confidence in the entire nuclear sector. The company has already cleared large areas of land for future reactors, hoping to secure a $400 million startup grant from the state and federal governments. If the NRC rejects Holtec’s request, the plant could face costs up to $750 million for replacing the reactor pressure vessel head, and additional upgrades could push expenses beyond $1. 5 billion over several years. Beyond the technical challenges, Holtec has not provided essential quality‑assurance paperwork that proves its welds meet ASME standards. This lack of documentation could halt the restart altogether, leaving Michigan’s nuclear ambitions in jeopardy and potentially damaging the reputation of other federally funded projects. The situation highlights the delicate balance between innovation, public funding, and safety in America’s nuclear future.